The increasing interest in successful weight management has led to considerable research into groundbreaking treatments. Recently , Retatrutide, here a combined -action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor stimulator, has exhibited positive results in patient trials, indicating potential for significant weight red